Robert G. Adams
Robert G. Adams's purchase track record
How the stock did after each of Robert G. Adams's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/6/2023 | NHC | $131K | +34.8% | +47.6% | +14.3% |
| 12/14/2022 | NHI | $57K | -3.5% | +0.1% | +9.4% |
| 8/15/2022 | NHI | $99K | -13.9% | -8.8% | -3.7% |
| 12/30/2021 | NHI | $115K | +4.6% | +9.0% | -20.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
NHI Sets Q3 2026 Earnings Date Amid REIT Sector Pressure. National Health Investors has scheduled its third-quarter 2026 earnings release and conference call. This announcement comes as the broader REIT sector faces headwinds from interest rate sensitivity, noted in recent market commentary. The stock currently trades near its 52-week low, with a dividend yield of 6.63%.
Transaction History
| NHC | ▲ Buy | Option Exercise | 4,000 | $277K | 6/8/2026 | View on chart |
| NHC | ▼ Sell | Gift | 4,000 | $0 | 6/8/2026 | View on chart |
| NHI | ▲ Buy | Option Exercise | 25,000 | $1.7M | 1/27/2026 | View on chart |
| NHI | ▲ Buy | Option Exercise | 10,000 | $733K | 1/27/2026 | View on chart |
| NHI | ▼ Sell | Tax Withholding | 31,093 | $2.5M | 1/27/2026 | View on chart |
| NHC | ▲ Buy | Option Exercise | 4,500 | $322K | 9/19/2025 | View on chart |
| NHI | ▲ Buy | Option Exercise | 25,000 | $1.3M | 3/28/2025 | View on chart |
| NHI | ▲ Buy | Option Exercise | 10,000 | $578K | 3/28/2025 | View on chart |
| NHI | ▼ Sell | Tax Withholding | 32,935 | $2.5M | 3/28/2025 | View on chart |
| NHI | ▲ Buy | Option Exercise | 10,000 | $547K | 3/28/2025 | View on chart |
| NHC | ▲ Buy | Option Exercise | 3,000 | $215K | 8/13/2024 | View on chart |
| NHC | ▼ Sell | Tax Withholding | 3,818 | $360K | 12/15/2023 | View on chart |
| NHC | ▲ Buy | Option Exercise | 7,500 | $584K | 12/15/2023 | View on chart |
| NHC | ▼ Sell | Tax Withholding | 6,203 | $584K | 12/15/2023 | View on chart |
| NHC | ▲ Buy | Option Exercise | 5,566 | $360K | 12/15/2023 | View on chart |
| NHI | ▼ Sell | Other | 85,411 | $0 | 10/1/2023 | View on chart |
| NHC | ▲ Buy | Open Market | 2,000 | $131K | 9/6/2023 | View on chart |
| NHI | ▲ Buy | Open Market | 1,000 | $57K | 12/14/2022 | View on chart |
| NHI | ▲ Buy | Open Market | 1,500 | $99K | 8/15/2022 | View on chart |
| NHC | ▲ Buy | Option Exercise | 1,934 | $125K | 5/18/2022 | View on chart |
| NHI | ▲ Buy | Open Market | 2,000 | $115K | 12/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
NHC highlighted in SeekingAlpha dividend champion roundup
SeekingAlpha’s weekly dividend review listed National HealthCare Corp as a dividend champion, contender and challenger. The mention underscores the company’s 3.07% yield and its position among dividend‑focused investors. With the stock trading near the middle of its 52‑week range, the coverage adds visibility to its dividend profile.
NHC highlighted in SeekingAlpha dividend champion roundup. SeekingAlpha’s weekly dividend review listed National HealthCare Corp as a dividend champion, contender and challenger. The mention underscores the company’s 3.07% yield and its position among dividend‑focused investors. With the stock trading near the middle of its 52‑week range, the coverage adds visibility to its dividend profile.